- Home
- ZCMD vs DARE Comparison
ZCMD vs DARE Comparison
Compare ZCMD & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- DARE
- Stock Information
- Founded
- ZCMD 2012
- DARE 2015
- Country
- ZCMD China
- DARE United States
- Employees
- ZCMD N/A
- DARE N/A
- Industry
- ZCMD Other Consumer Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- DARE Health Care
- Exchange
- ZCMD Nasdaq
- DARE Nasdaq
- Market Cap
- ZCMD 28.5M
- DARE 26.3M
- IPO Year
- ZCMD 2020
- DARE N/A
- Fundamental
- Price
- ZCMD $0.99
- DARE $2.42
- Analyst Decision
- ZCMD
- DARE Strong Buy
- Analyst Count
- ZCMD 0
- DARE 3
- Target Price
- ZCMD N/A
- DARE $12.50
- AVG Volume (30 Days)
- ZCMD 38.9K
- DARE 4.6M
- Earning Date
- ZCMD 01-01-0001
- DARE 08-11-2025
- Dividend Yield
- ZCMD N/A
- DARE N/A
- EPS Growth
- ZCMD N/A
- DARE N/A
- EPS
- ZCMD N/A
- DARE N/A
- Revenue
- ZCMD $15,864,773.00
- DARE $25,909.00
- Revenue This Year
- ZCMD N/A
- DARE $74,787.57
- Revenue Next Year
- ZCMD N/A
- DARE $141.76
- P/E Ratio
- ZCMD N/A
- DARE N/A
- Revenue Growth
- ZCMD N/A
- DARE N/A
- 52 Week Low
- ZCMD $0.95
- DARE $2.11
- 52 Week High
- ZCMD $2.97
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- ZCMD 38.07
- DARE 42.12
- Support Level
- ZCMD $1.02
- DARE $2.44
- Resistance Level
- ZCMD $1.08
- DARE $2.80
- Average True Range (ATR)
- ZCMD 0.07
- DARE 0.19
- MACD
- ZCMD -0.01
- DARE -0.01
- Stochastic Oscillator
- ZCMD 1.77
- DARE 4.94
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.